Clin Gastroenterol Hepatol
http://www.ncbi.nlm.nih.gov/pubmed/35066137
https://connects.catalyst.harvard.edu/Profiles/profile/190923414
Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor a Antagonists in Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
http://www.ncbi.nlm.nih.gov/pubmed/35066137
https://connects.catalyst.harvard.edu/Profiles/profile/190923414